Impact of devascularization and tissue procurement on cell number and RNA integrity in prostatectomy tissue

Minimizing the time between tissue devascularization in robot-assisted laparoscopic radical prostatectomy (RALP) and tissue procurement should produce the highest quality tissue for research study. This study examines the relationship between intra-operative time and two indicators of tissue integrity: number of epithelial cells per gram of tissue and RNA integrity numbers (RINs).

The study also compares the RIN values of tissue obtained intra-operatively by biopsy, before and after devascularization, to those from RALP specimen tissue, obtained through the routine research tissue procurement process.

Prostate tissues from two series of patients were analyzed. In the first, tissue from 18 patients undergoing RALP was analyzed for number of epithelial cells per gram of tissue. In the second, RIN values of tissue from 46 patients involved in a clinical study were analyzed. RIN values were assessed from RALP specimen tissue as well as tissue removed intra-operatively by biopsy, before and after devascularization.

Time from RALP to tissue procurement was not significantly associated with number of epithelial cells per gram of tissue or with RIN values. RINs of biopsy tissue obtained intra-operatively before and after devascularization were similar. However, the RIN values of tissue from RALP specimens were significantly higher than those of biopsy tissue obtained either before or after devascularization.

Tissue quality, defined by number of epithelial cells or RIN values, was not affected by time between devascularization and procurement. Obtaining tissue from intra-operative biopsies, either before or after devascularization, is not necessary and actually produced lower RINs than found in tissue from RALP specimens, obtained through the routine research tissue procurement process. Prostate © 2015 Wiley Periodicals, Inc.

The Prostate. 2015 Sep 09 [Epub ahead of print]

Rochelle Payne Ondracek, Jinrong Cheng, Kalyan J Gangavarapu, Gissou Azabdaftari, Jeff Woltz, Elizabeth Brese, Angela Omilian, Wiam Bshara, Wendy J Huss, James L Mohler, James R Marshall

Department of Cancer Prevention and Population Science, Roswell Park Cancer Institute, Buffalo, New York. , Department of Cancer Prevention and Population Science, Roswell Park Cancer Institute, Buffalo, New York. , Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York. , Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York. , Department of Cancer Prevention and Population Science, Roswell Park Cancer Institute, Buffalo, New York. , Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York. , Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York. , Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York. , Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York. , Department of Urology, Roswell Park Cancer Institute, Buffalo, New York. , Department of Cancer Prevention and Population Science, Roswell Park Cancer Institute, Buffalo, New York.

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe